NCT00563147 2011-10-04A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell CarcinomaAVEO Pharmaceuticals, Inc.Phase 1 Completed28 enrolled